Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Mar 14;194(10):E389.
doi: 10.1503/cmaj.81197.

Concerns about subgroup analyses and reason for stopping remdesivir trial

Bharath Kumar Tirupakuzhi Vijayaraghavan  1
Affiliations
Comment

Concerns about subgroup analyses and reason for stopping remdesivir trial

Bharath Kumar Tirupakuzhi Vijayaraghavan. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Bharath Kumar Tirupakuzhi Vijayaraghavan was a site investigator at Apollo Hospitals for the World Health Organization Solidarity trial in India.

Comment in

Comment on

  • Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial.
    Ali K, Azher T, Baqi M, Binnie A, Borgia S, Carrier FM, Cavayas YA, Chagnon N, Cheng MP, Conly J, Costiniuk C, Daley P, Daneman N, Douglas J, Downey C, Duan E, Duceppe E, Durand M, English S, Farjou G, Fera E, Fontela P, Fowler R, Fralick M, Geagea A, Grant J, Harrison LB, Havey T, Hoang H, Kelly LE, Keynan Y, Khwaja K, Klein G, Klein M, Kolan C, Kronfli N, Lamontagne F, Lau R, Fralick M, Lee TC, Lee N, Lim R, Longo S, Lostun A, MacIntyre E, Malhamé I, Mangof K, McGuinty M, Mergler S, Munan MP, Murthy S, O'Neil C, Ovakim D, Papenburg J, Parhar K, Parvathy SN, Patel C, Perez-Patrigeon S, Pinto R, Rajakumaran S, Rishu A, Roba-Oshin M, Rushton M, Saleem M, Salvadori M, Scherr K, Schwartz K, Semret M, Silverman M, Singh A, Sligl W, Smith S, Somayaji R, Tan DHS, Tobin S, Todd M, Tran TV, Tremblay A, Tsang J, Turgeon A, Vakil E, Weatherald J, Yansouni C, Zarychanski R; Canadian Treatments for COVID-19 (CATCO); Association of Medical Microbiology and Infectious Disease Canada (AMMI) Clinical Research Network and the Canadian Critical Care Trials Group. Ali K, et al. CMAJ. 2022 Feb 22;194(7):E242-E251. doi: 10.1503/cmaj.211698. Epub 2022 Jan 19. CMAJ. 2022. PMID: 35045989 Free PMC article. Clinical Trial.

References

    1. Ali K, Azher T, Baqi M, et al. . Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial. CMAJ 2022;194:E242–51. - PMC - PubMed
    1. WHO Solidarity Trial Consortium. Repurposed antiviral drugs for COVID-19—interim Solidarity trial results. N Engl J Med 2021;384:497–511. - PMC - PubMed
    1. Gottlieb RL, Vaca CE, Paredes R, et al. . Early remdesivir to prevent progression to severe COVID-19 in outpatients. N Engl J Med 2022;386:305–15. - PMC - PubMed

MeSH terms